Publications by authors named "Claus Sundgreen"

Claim this Profile
S
Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.
Michael Benatar, Thomas Hansen, Dror Rom, Marie A Geist, Thomas Blaettler, Claus Sundgreen

Lancet Neurol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial.
Pedro M Machado, Michael P McDermott, Thomas Blaettler, Claus Sundgreen, Anthony A Amato

Lancet Neurol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathogenic classification of LPL gene variants reported to be associated with LPL deficiency.
Rute Rodrigues, Marta Artieda, Diego Tejedor, Antonio Martínez, Pavlina Konstantinova, Claus Sundgreen

J Clin Lipidol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-hypertensive treatment preserves appetite suppression while preventing cardiovascular adverse effects of tesofensine in rats.
Bo Hjorth Bentzen, Morten Grunnet, Lars Hyveled-Nielsen, Claus Sundgreen, Jørgen Buus Lassen

Obesity (Silver Spring)· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis